Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tim Lugo is an analyst at William Blair. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/15/2024 | EYEN | Buy Now | Eyenovia | $1.66 | — | Tim Lugo34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/30/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.32 | — | Tim Lugo34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/12/2024 | RVNC | Buy Now | Revance Therapeutics | — | — | Tim Lugo34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/31/2024 | APLT | Buy Now | Applied Therapeutics | $0.51 | — | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
| 04/15/2024 | LENZ | Buy Now | LENZ Therapeutics | $24.00 | — | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
| 03/28/2024 | SLDB | Buy Now | Solid Biosciences | $4.83 | 728.16% | Tim Lugo34% | → $40 | Initiates | → Outperform | Get Alert |
| 03/12/2024 | ZVRA | Buy Now | Zevra Therapeutics | $7.95 | — | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
| 01/29/2024 | ABBV | Buy Now | AbbVie | $212.25 | — | Tim Lugo34% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 12/18/2023 | ALLK | Buy Now | Allakos | $0.25 | — | Tim Lugo34% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/13/2023 | ACRS | Buy Now | Aclaris Therapeutics | $1.62 | — | Tim Lugo34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/01/2023 | EYEN | Buy Now | Eyenovia | $1.66 | — | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
| 09/21/2023 | TVTX | Buy Now | Travere Therapeutics | $20.68 | — | Tim Lugo34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 09/20/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $12.00 | — | Tim Lugo34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/25/2023 | ABBV | Buy Now | AbbVie | $212.25 | — | Tim Lugo34% | — | Initiates | → Market Perform | Get Alert |
| 01/04/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $12.00 | — | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
| 07/22/2022 | VTGN | Buy Now | VistaGen Therapeutics | $2.67 | — | Tim Lugo34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/08/2022 | BBI | Buy Now | Brickell Biotech | — | — | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
| 12/22/2021 | ALLK | Buy Now | Allakos | $0.25 | — | Tim Lugo34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/22/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.32 | — | Tim Lugo34% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 10/11/2021 | ADMS | Buy Now | Adamas Pharmaceuticals | — | — | Tim Lugo34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/13/2021 | KNTE | Buy Now | Kinnate Biopharma | — | — | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
| 06/16/2021 | SAGE | Buy Now | Sage Therapeutics | $8.25 | 651.52% | Tim Lugo34% | → $62 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/04/2021 | VTGN | Buy Now | VistaGen Therapeutics | $2.67 | — | Tim Lugo34% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 11/24/2020 | AVIR | Buy Now | Atea Pharmaceuticals | $3.17 | — | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
| 08/20/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.32 | — | Tim Lugo34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/08/2020 | XENE | Buy Now | Xenon Pharmaceuticals | $34.94 | — | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
| 08/28/2019 | VTGN | Buy Now | VistaGen Therapeutics | $2.67 | — | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
| 08/13/2018 | ALLK | Buy Now | Allakos | $0.25 | — | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
| 09/22/2017 | AKTX | Buy Now | Akari Therapeutics | $1.30 | — | Tim Lugo34% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 05/30/2017 | BHVN | Buy Now | Biohaven | $28.75 | 60% | Tim Lugo34% | → $46 | Initiates | → Outperform | Get Alert |
| 05/30/2017 | OVID | Buy Now | Ovid Therapeutics | $0.49 | — | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
| 05/12/2017 | AKTX | Buy Now | Akari Therapeutics | $1.30 | — | Tim Lugo34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/25/2017 | AKRX | Buy Now | Akorn | — | — | Tim Lugo34% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/06/2017 | RTRX | Buy Now | Retrophin | — | — | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
| 03/23/2016 | AKRX | Buy Now | Akorn | — | — | Tim Lugo34% | $58 → $36 | Maintains | Outperform | Get Alert |
| 05/05/2014 | ADMS | Buy Now | Adamas Pharmaceuticals | — | — | Tim Lugo34% | → $35 | Initiates | → Outperform | Get Alert |
| 09/12/2012 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.32 | — | Tim Lugo34% | — | — | — | Get Alert |
